Physician profile
Thomas M Baer
NPI 1336252097
$173.47
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.53 · 2020: $22.27 · 2022: $57.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $67.67 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $22.52 | 2019 | |
| Kerecis Limited | $20.34 | 2022 | |
| Pfizer INC. | $13.11 | 2019 | |
| Abbvie INC. | $13.00 | 2022 | |
| Ironwood Pharmaceuticals, INC | $12.62 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.50 | 2019 | |
| Lilly USA, LLC | $11.71 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Baer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.